Skip to main content
. 2023 Sep 9;9(9):e20015. doi: 10.1016/j.heliyon.2023.e20015

Fig. 2.

Fig. 2

Kaplan–Meier analysis for OS. (A) OS for HBV-related HCC patients with PVTT with or without adjuvant aspirin (40 patients vs. 40 patients) after surgery (P = 0.078); (B) OS for patients with HBV-related HCC and type I and II PVTT with or without adjuvant aspirin (25 patients vs. 27 patients) after surgery (P = 0.033); (C) OS for patients with HBV-related HCC and type III and IV PVTT with or without adjuvant aspirin (15 patients vs. 13 patients) after surgery (P = 0.286).